Proficiency testing for bacterial whole genome sequencing: an end-user survey of current capabilities, requirements and priorities

BMC Infectious Diseases

Rene S Hendriksen³  Errol Strain²  James Pettengill²  William J Wolfgang⁵  Susanne Karlsmose Pedersen³  Vitali Sintchenko⁴  Jacob Moran-Gilad¹ 

[1] Surveillance and Pathogenomics Israeli Centre of Excellence (SPICE), National Institute for Biotechnology in the Negev, Ben-Gurion University, Beer-Sheva, Israel;Biostatistics Branch, US Food and Drug Administration, College Park, Maryland, USA;Technical University of Denmark, National Food Institute, Research Group of Microbial Genomics and Antimicrobial Resistance, National Food Institute, Technical University of Denmark, Kemitorvet, Building 204, ground floor, Kongens Lyngby, DK - 2800, Denmark;Centre for Infectious Diseases and Microbiology – Public Health, Institute of Clinical Pathology and Medical Research – Pathology West, Westmead Hospital, Sydney, Australia;Bacteriology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, USA

关键词: Standards;    Microbiology;    Public health;    End-users;    Survey;    Next-generation sequencing;    Bioinformatics;    Proficiency;   

Others  :  1172080
DOI  :  10.1186/s12879-015-0902-3

 received in 2014-11-13, accepted in 2015-03-13,  发布年份 2015

【 摘 要 】

The advent of next-generation sequencing (NGS) has revolutionised public health microbiology. Given the potential impact of NGS, it is paramount to ensure standardisation of ‘wet’ laboratory and bioinformatic protocols and promote comparability of methods employed by different laboratories and their outputs. Therefore, one of the ambitious goals of the Global Microbial Identifier (GMI) initiative (http://www.globalmicrobialidentifier.org/ webcite) has been to establish a mechanism for inter-laboratory NGS proficiency testing (PT). This report presents findings from the survey recently conducted by Working Group 4 among GMI members in order to ascertain NGS end-use requirements and attitudes towards NGS PT. The survey identified the high professional diversity of laboratories engaged in NGS-based public health projects and the wide range of capabilities within institutions, at a notable range of costs. The priority pathogens reported by respondents reflected the key drivers for NGS use (high burden disease and ‘high profile’ pathogens). The performance of and participation in PT was perceived as important by most respondents. The wide range of sequencing and bioinformatics practices reported by end-users highlights the importance of standardisation and harmonisation of NGS in public health and underpins the use of PT as a means to assuring quality. The findings of this survey will guide the design of the GMI PT program in relation to the spectrum of pathogens included, testing frequency and volume as well as technical requirements. The PT program for external quality assurance will evolve and inform the introduction of NGS into clinical and public health microbiology practice in the post-genomic era.

【 授权许可】

   
2015 Moran-Gilad et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Bertelli C, Greub G: Rapid bacterial genome sequencing: methods and applications in clinical microbiology. Clin Microbiol Infect 2013, 19:803-13.
• [2]Long SW, Williams D, Valson C, Cantu CC, Cernoch P, Musser JM, et al.: A genomic day in the life of a clinical microbiology laboratory. J Clin Microbiol 2013, 51:1272-7.
• [3]Didelot X, Bowden R, Wilson DJ, Peto TEA, Crook DW: Transforming clinical microbiology with bacterial genome sequencing. Nature Rev Genetics 2012, 13:601-12.
• [4]Kupferschmidt K: Epidemiology. Outbreak detectives embrace the genome era. Science 2011, 333:1818-9.
• [5]Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, et al.: Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: A retrospective observational study. Lancet Infect Dis 2013, 13:137-46.
• [6]Roetzer A, Diel R, Kohl TA, Rückert C, Nübel U, Blom J, et al.: Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: A longitudinal molecular epidemiological study. PLoS Med 2013, 10:e1001387.
• [7]Sherry NL, Porter JL, Seemann T, Watkins A, Stinear TP, Howden BP: Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory. J Clin Microbiol 2013, 51:1396-401.
• [8]Maiden M, van Rensburg MJ J, Bray JE, Earle SG, Ford SA, Jolley KA, et al.: MLST revisited: the gene-by-gene approach to bacterial genomics. Nat Rev Microbiol 2013, 11:728-36.
• [9]Relman DA: Microbial genomics and infectious diseases. New Engl J Med 2011, 365:347-57.
• [10]Köser CU, Ellington MJ, Cartwright EJ, Gillespie SH, Brown NM, Farrington M, et al.: Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathogens 2012, 8:e1002824.
• [11]Dunne WM Jr, Westblade LF, Ford B: Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis 2012, 31:1719-26.
• [12]Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, Brodkin E, et al.: Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. New Engl J Med 2011, 364:730-9.
• [13]Gilmour MW, Graham M, Reimer A, Van Domselaar G: Public health genomics and the new molecular epidemiology of bacterial pathogens. Public Health Genomics 2013, 16:25-30.
• [14]Aarestrup FM, Brown EW, Detter C, Gerner-Smidt P, Gilmour MW, Harmsen D, et al.: Integrating genome-based informatics to modernize global disease monitoring, information sharing, and response. Emerg Infect Dis 2012, 18:e1.
• [15]Perspectives of a global, real-time microbiological genomic identification system - implications for national and global detection and control of infectious diseases. Consensus report of an expert meeting 1-2 September 2011, Bruxelles, Belgium. Available at: http://www.food.dtu.dk/english/~/media/institutter/foedevareinstituttet/publikationer/pub-2011/consensus%20report%20perspectives%20of%20a%20global,%20real-time.ashx.
• [16]Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, et al.: Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 2012, 30:1033-6.
• [17]Underwood AP, Dallman T, Thomson NR, Williams M, Harker K, Perry N, et al.: Public health value of next-generation DNA sequencing of enterohaemorrhagic Escherichia coli isolates from an outbreak. J Clin Microbiol 2013, 51:232-7.
• [18]Leekitcharoenphon P, Nielsen EM, Kaas RS, Lund O, Aarestrup FM: Evaluation of whole genome sequencing for outbreak detection of Salmonella enterica. PLoS One 2014, 2:e87991.
• [19]Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM, et al.: Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol 2014, 52:1501-10.
• [20]Gullapalli RR, Desai KV, Santana-Santos L, Kant JA, Becich MJ: Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics. J Pathol Inform 2012, 3:40.
• [21]Wyres KL, Conway CC, Garg S, Queiroz C, Reumann M, Holt K, et al.: WGS Analysis and interpretation in clinical and public health microbiology laboratories: what are the requirements and how do existing tools compare? Pathogens 2014, 3:437-58.